Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advanced Diagnostics 2016

Manjiri Bakre's Biography



Manjiri Bakre, Founder and CEO, OncoStem Diagnostics Pvt Ltd.

Dr Manjiri Bakre, a gold medalist from R. Ruia College, University of Mumbai for B.Sc (Microbiology), has M.Sc in Microbiology/Biochemistry from M S U, Baroda. She received PhD in Cell Biology from the Indian Institute of Science, Bangalore.
Post Ph D she has worked in USA at Mt Sinai School of Medicine, NY and at Moores Cancer Center, University of California at San Diego, CA on very diverse cellular signal transduction areas such as perception of bitter taste and cancer biology. In 2003, she moved to Genome Institute of Singapore and worked on human embryonic stem cells and cancer stem cells. Manjiri moved back to India in 2007 and led a group in cancer drug discovery in a biotech company followed by multi-disciplinary research on ‘point-of-care’ diagnostics at Philips Research in Bangalore and The Netherlands. In 2011 she founded OncoStem Diagnostics Pvt Ltd. focused on developing novel cancer diagnostic tests. The company is funded by venture capitalist.
She is a recipient of Young Scientist Award given by International Union of Biochemists and Molecular Biologists (IUBMB). She has published in many peer reviewed journals such as Nature Medicine, has patents, mentored students and presented work at international conferences. She has extensive experience in multiple areas of biology as well as in technologies such as microfluidic assays, microarrays etc. In addition her work published from Singapore has been given Best Paper Award- given to top 1% papers published annually by Journal of Biological Chemists.

Manjiri  Bakre Image

Development and Validation of Novel Diagnostic Test For Prediction of Risk of Recurrence for Breast Cancer Patients:Beyond ER, PR & Her-2/neu

Thursday, 26 May 2016 at 14:30

Add to Calendar ▼2016-05-26 14:30:002016-05-26 15:30:00Europe/LondonDevelopment and Validation of Novel Diagnostic Test For Prediction of Risk of Recurrence for Breast Cancer Patients:Beyond ER, PR and Her-2/neuAdvanced Diagnostics 2016 in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com

This talk will focus on development and validation of OncoStem:Breast test for ER+/PR+/Her2- or +/Lymph node – or + IDC of breast patients.


Add to Calendar ▼2016-05-26 00:00:002016-05-27 00:00:00Europe/LondonAdvanced Diagnostics 2016Advanced Diagnostics 2016 in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com